雷傑納隆藥廠 REGN

-

已收盤：-

本益比明細


年季	收盤價	本業佔比%	本益比(近四季)	每股稅後盈餘(元)	營業利益(千)	稅後純益(百萬)
2025Q2	525.00		12.60	12.81	1,079,500	1,392
2025Q1	634.23	64.76	15.71	7.27	591,700	809
2024Q4	712.33	102.23	16.82	8.11	990,200	918
2024Q3	1051.24	78.28	24.90	11.55	1,179,500	1,341
2024Q2	1051.03	65.10	30.02	12.41	1,069,600	1,432
2024Q1	962.49	104.83	26.72	6.27	751,400	722
2023Q4	878.29	83.45	23.98	10.20	972,900	1,160
2023Q3	822.96	98.44	20.78	8.89	1,111,000	1,008
2023Q2	718.54	92.26	18.34	8.51	1,016,500	968
2023Q1	821.67	108.07	21.48	7.17	946,700	818
2022Q4	721.49	85.45	14.63	10.49	1,146,800	1,197
2022Q3	688.87	80.24	13.20	11.66	1,223,700	1,316
2022Q2	591.13	113.68	8.18	7.46	1,109,900	852
2022Q1	698.42	117.10	9.39	8.61	1,258,500	974
2021Q4	631.52	104.85		19.68	2,639,700	2,229
2021Q3	605.18	100.90	16.17	14.22	1,847,200	1,632
2021Q2	558.54	88.85	14.86	27.98	3,347,200	3,099
2021Q1	473.14	87.78	14.43	10.09	1,112,700	1,115
2020Q4	483.11	94.16	14.67	10.16	1,167,000	1,149
2020Q3	559.78	102.78	18.87	7.33	1,053,100	842